Amwill Healthcare IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Feb 05 to Feb 07 2025
Price Band
₹111
Current GMP
₹88.85(-19.95%)
Subscription
5.73 times
IPO Details
| IPO Date | February 5, 2025 to February 7, 2025 |
| Listing Date | February 12, 2025 |
| Face Value | ₹10 per share |
| Issue Price | ₹111 per share |
| Lot Size | 1,200 Shares |
| Total Issue Size | 54,03,600 shares (aggregating up to ₹59.98 Cr) |
| Fresh Issue | 44,03,600 shares (aggregating up to ₹48.88 Cr) |
| Offer for Sale | 10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE SME |
| Share Holding Pre Issue | 1,56,00,000 shares |
| Share Holding Post Issue | 2,00,03,600 shares |
| Market Maker Portion | 2,71,200 sharesGlobalworth Securities Limited |
IPO Date
February 5, 2025 to February 7, 2025
Listing Date
February 12, 2025
Face Value
₹10 per share
Issue Price
₹111 per share
Lot Size
1,200 Shares
Total Issue Size
54,03,600 shares (aggregating up to ₹59.98 Cr)
Fresh Issue
44,03,600 shares (aggregating up to ₹48.88 Cr)
Offer for Sale
10,00,000 shares of ₹10 (aggregating up to ₹11.10 Cr)
Issue Type
Book Built Issue IPO
Listing At
BSE SME
Share Holding Pre Issue
1,56,00,000 shares
Share Holding Post Issue
2,00,03,600 shares
Market Maker Portion
2,71,200 sharesGlobalworth Securities Limited
IPO Subscription Details
| Market Maker | 1 |
| Qualified Institutions | 7.8 |
| Non-Institutional Buyers*** | 5.66 |
| Retail Investors | 4.77 |
| Total ** | 5.73 |
Market Maker
1
Qualified Institutions
7.8
Non-Institutional Buyers***
5.66
Retail Investors
4.77
Total **
5.73
Day Wise Sub
| Day | QIB | NII* | Retail | Total |
|---|---|---|---|---|
| Day 1 Feb 5, 2025 | 2.19 | 0.51 | 1 | 1.04 |
| Day 2 Feb 6, 2025 | 2.19 | 0.53 | 1.92 | 1.42 |
| Day 3 Feb 7, 2025 | 7.8 | 5.66 | 4.77 | 5.73 |
DayDay 1
Feb 5, 2025
QIB2.19
NII*0.51
Retail1
Total1.04
DayDay 2
Feb 6, 2025
QIB2.19
NII*0.53
Retail1.92
Total1.42
DayDay 3
Feb 7, 2025
QIB7.8
NII*5.66
Retail4.77
Total5.73
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 12-02-2025 | 111.00 | 0(0.00%) | 111 |
| 11-02-2025 | 111.00 | 0(0.00%) | 111 |
| 10-02-2025 | 111.00 | 0(0.00%) | 111 |
| 09-02-2025 | 111.00 | 0(0.00%) | 111 |
| 08-02-2025 | 111.00 | 0(0.00%) | 111 |
| 07-02-2025 | 111.00 | 0(0.00%) | 111 |
| 06-02-2025 | 111.00 | 11(9.91%) | 122 |
| 05-02-2025 | 111.00 | 6(5.41%) | 117 |
| 04-02-2025 | 111.00 | 14(12.61%) | 125 |
| 03-02-2025 | 111.00 | 0(0.00%) | 111 |
| 02-02-2025 | 111.00 | 0(0.00%) | 111 |
| 01-02-2025 | 111.00 | 0(0.00%) | 111 |
| 31-01-2025 | 111.00 | 0(0.00%) | 111 |
Date12-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date11-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date10-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date09-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date08-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date07-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date06-02-2025
Price111.00
GMP11(9.91%)
Estimate List Price122
Date05-02-2025
Price111.00
GMP6(5.41%)
Estimate List Price117
Date04-02-2025
Price111.00
GMP14(12.61%)
Estimate List Price125
Date03-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date02-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date01-02-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
Date31-01-2025
Price111.00
GMP0(0.00%)
Estimate List Price111
IPO Important Dates
| IPO Open Date | Wed, Feb 5, 2025 |
| IPO Close Date | Fri, Feb 7, 2025 |
| Tentative Allotment | Mon, Feb 10, 2025 |
| Initiation of Refunds | Tue, Feb 11, 2025 |
| Credit of Shares to Demat | Tue, Feb 11, 2025 |
| Tentative Listing Date | Wed, Feb 12, 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on February 7, 2025 |
IPO Open Date
Wed, Feb 5, 2025
IPO Close Date
Fri, Feb 7, 2025
Tentative Allotment
Mon, Feb 10, 2025
Initiation of Refunds
Tue, Feb 11, 2025
Credit of Shares to Demat
Tue, Feb 11, 2025
Tentative Listing Date
Wed, Feb 12, 2025
Cut-off time for UPI mandate confirmation
5 PM on February 7, 2025
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 1200 | ₹1,33,200 |
| Retail (Max) | 1 | 1200 | ₹1,33,200 |
| HNI (Min) | 2 | 2,400 | ₹2,66,400 |
ApplicationRetail (Min)
Lots1
Shares1200
Amount₹1,33,200
ApplicationRetail (Max)
Lots1
Shares1200
Amount₹1,33,200
ApplicationHNI (Min)
Lots2
Shares2,400
Amount₹2,66,400
Financial Information
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 |
| Assets | 28.89 | 18.98 | 12.39 |
| Revenue | 23.25 | 44.28 | 30.28 |
| Profit After Tax | 6.52 | 12.54 | 3.11 |
| Net Worth | 23.68 | 17.16 | 4.6 |
| Reserves and Surplus | 8.08 | 17.11 | 4.57 |
Period EndedPeriod Ended
30 Sep 202430 Sep 2024
31 Mar 202431 Mar 2024
31 Mar 202331 Mar 2023
Period EndedAssets
30 Sep 202428.89
31 Mar 202418.98
31 Mar 202312.39
Period EndedRevenue
30 Sep 202423.25
31 Mar 202444.28
31 Mar 202330.28
Period EndedProfit After Tax
30 Sep 20246.52
31 Mar 202412.54
31 Mar 20233.11
Period EndedNet Worth
30 Sep 202423.68
31 Mar 202417.16
31 Mar 20234.6
Period EndedReserves and Surplus
30 Sep 20248.08
31 Mar 202417.11
31 Mar 20234.57
IPO Reservation
| Anchor Investor Shares Offered | - |
| Market Maker Shares Offered | 2,71,200 (5.02%) |
| QIB Shares Offered | 10,26,000 (18.99%) |
| NII (HNI) Shares Offered | 20,53,200 (38%) |
| Retail Shares Offered | 20,53,200 (38%) |
| Total Shares Offered | 54,03,600 (100%) |
Anchor Investor Shares Offered
-
Market Maker Shares Offered
2,71,200 (5.02%)
QIB Shares Offered
10,26,000 (18.99%)
NII (HNI) Shares Offered
20,53,200 (38%)
Retail Shares Offered
20,53,200 (38%)
Total Shares Offered
54,03,600 (100%)
Information about company
Incorporated in August 2017, Amwill Health Care Limited is a derma-cosmetic development firm that collaborates with contract manufacturers, distributors, and third-party product development agencies. This collaboration has enhanced the company's manufacturing, packaging, and distribution capabilities.
The product portfolio of the Company is divided into two categories, namely,
Development of generic dermatological solutions and
Formulating targeted solutions for dermatological issues.
The company markets its products in Karnataka, Andhra Pradesh, and Telangana, focusing on strengthening its presence before entering new markets to build a customer base.
The company develops products for dermatological disorders, including acne, fungal infections, anti-aging, histaminic, periorbital hyperpigmentation, scabies, perspiration, trichology, and vitiligo.
As of September 30, 2024, the company has 84 employees on payroll.
Competitive Strength
Extensive product portfolio supported by product formulation capabilities
Provision of high-quality product development through tie-ups with contract manufacturers and prototype developers
Well-experienced management team with proven project management and implementation skills
Asset-light business model.
Objectives of IPO
The company proposes to utilize the Net Proceeds in the following manner.
Funding of working capital requirements of the Company
Marketing and brand-building activities
General corporate purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App